Avricore Health (AVCRF) Cash & Current Investments (2009 - 2025)
Avricore Health (AVCRF) posted quarterly Cash & Current Investments of $163436.9 for Q4 2025, down 79.84% YoY from $810621.8 in Q4 2024, and down 57.7% sequentially from $386389.6 in Q3 2025.
Avricore Health (AVCRF) Cash & Current Investments (2009 - 2025) Analysis & Trends
Avricore Health has disclosed Cash & Current Investments across 17 years of filings, most recently posting $163436.9 for Q4 2025.
- In Q4 2025, Cash & Current Investments fell 79.84% year-over-year to $163436.9; the TTM figure through Dec 2025 stood at $163436.9 (down 79.84% YoY), while the FY2025 annual figure was $163125.8, down 80.28% from the prior year.
- Cash & Current Investments fell to $163436.9 in Q4 2025, from $386389.6 in the prior quarter.
- Over the last five years, Cash & Current Investments for AVCRF reached as high as $2.1 million in Q2 2021 and fell as low as $163436.9 in Q4 2025.
- The 5-year median for Cash & Current Investments is $594680.2 (2024), against an average of $897509.4.
- Annual changes were most pronounced in 2021 — Cash & Current Investments surged 5477.08% — and 2025, when it sank 79.84%.
- A 5-year view of Cash & Current Investments shows it stood at $1.8 million in 2021, then tumbled by 75.19% to $457144.1 in 2022, then plunged by 55.56% to $203151.2 in 2023, then surged by 299.02% to $810621.8 in 2024, then slumped by 79.84% to $163436.9 in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $163436.9, $386389.6, and $617201.3 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 462.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 3.26 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 5.70 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 200.53 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 1.10 Bn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 1.81 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 2.10 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 1.16 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 60.60 Mn |
| 10 | Avricore Health | - | - | - | 170,607.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 170,607.73 |
| Sep 30, 2025 | 393,655.97 |
| Jun 30, 2025 | 624,418.44 |
| Dec 31, 2024 | 817,780.33 |
| Sep 30, 2024 | 579,489.72 |
| Jun 30, 2024 | 413,540.40 |
| Dec 31, 2023 | 210,496.58 |
| Sep 30, 2023 | 298,022.35 |
| Jun 30, 2023 | 359,102.28 |
| Dec 31, 2022 | 464,511.09 |
| Sep 30, 2022 | 904,092.73 |
| Jun 30, 2022 | 1.38 Mn |
| Sep 30, 2021 | 2.01 Mn |
| Sep 30, 2015 | 1.70 Mn |
| Jun 30, 2015 | 3.85 Mn |
| Mar 31, 2015 | 2.01 Mn |
| Dec 31, 2014 | 642,739.52 |
| Sep 30, 2014 | 271,636.50 |
| Jun 30, 2014 | 281,267.03 |
| Mar 31, 2014 | 315,016.03 |